These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 723150)

  • 21. Acute renal effects of sulindac and indomethacin in chronic renal failure.
    Berg KJ; Talseth T
    Clin Pharmacol Ther; 1985 Apr; 37(4):447-52. PubMed ID: 3884224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potassium-aldosterone response in dogs with chronic renal insufficiency.
    Bourgoignie JJ; Gavellas G; Van Putten V; Berl T
    Miner Electrolyte Metab; 1985; 11(3):150-4. PubMed ID: 4010647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal lithium excretion in man.
    Thomsen K; Schou M
    Am J Physiol; 1968 Oct; 215(4):823-7. PubMed ID: 5676383
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary aldosteronism.
    Corry DB; Tuck ML
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):511-29. PubMed ID: 8575407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma renin and aldosterone after renal transplantation.
    Beckerhoff R; Uhlschmid G; Vetter W; Armbruster H; Siegenthaler W
    Kidney Int; 1974 Jan; 5(1):39-46. PubMed ID: 4360444
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of aldosterone and spirolactone on renal sodium and potassium excretion during mannitol diuresis.
    Nagasaka M; Nakamura K; Kinouchi T; Kurosawa T; Ito T
    Jpn Heart J; 1968 Jan; 9(1):3-12. PubMed ID: 5301394
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease.
    Weidmann P; Maxwell MH; Rowe P; Winer R; Massry SG
    Nephron; 1975; 15(1):35-49. PubMed ID: 165438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma aldosterone during lithium treatment.
    Pedersen EB; Darling S; Kierkegaard-Hansen A; Amidisen A
    Neuropsychobiology; 1977; 3(2-3):153-9. PubMed ID: 896002
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of mineralocorticoids in the natriuresis of water immersion in man.
    Epstein M; Katsikas JL; Duncan DC
    Circ Res; 1973 Feb; 32(2):228-36. PubMed ID: 4685967
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of aldosterone in the potassium excretion in patients with advanced chronic renal failure (author's transl)].
    Sudo S
    Nihon Jinzo Gakkai Shi; 1981 Jun; 23(6):825-38. PubMed ID: 7311126
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 33. [Plasma aldosterone in chronic renal insufficiency and in anephric patients (author's transl)].
    Botey A; Bestard J; Mauri M; López Pedret J; Revert L
    Med Clin (Barc); 1979 Jul; 73(3):94-102. PubMed ID: 470511
    [No Abstract]   [Full Text] [Related]  

  • 34. [Possible mechanisms of polyuria in progressive chronic renal failure].
    Natochin IuV; Bogolepova AE
    Ter Arkh; 2000; 72(6):15-20. PubMed ID: 10900642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure--role of local adrenal renin-angiotensin system.
    Endemann DH; Wolf K; Boeger CA; Riegger GA; Krämer BK
    Nephron Physiol; 2004; 97(2):p37-44. PubMed ID: 15218317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The occurrence of hyperaldosteronism in infants with congestive heart failure.
    Baylen BG; Johnson G; Tsang R; Srivastava L; Kaplan S
    Am J Cardiol; 1980 Feb; 45(2):305-10. PubMed ID: 6986745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(2):145-56. PubMed ID: 4281879
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperkalemia in salt-wasting nephropathy. Study of the mechanism.
    Popovtzer MM; Katz FH; Pinggera WF; Robinette J; Halgrimson CG; Butkus DE
    Arch Intern Med; 1973 Aug; 132(2):203-8. PubMed ID: 4719548
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration.
    Adamson AR; Jamieson SW
    J Endocrinol; 1972 Jun; 53(3):425-31. PubMed ID: 4556970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.